Subscribe to RSS
DOI: 10.1055/s-0038-1655087
The Effect of Warfarin Sodium on the Duration of Platelet Aggregation
Supported in part by United States Public Health Service Research Grant HE-03973.Publication History
Publication Date:
24 July 2018 (online)

Summary
The effect of the administration of warfarin sodium (Coumadin®) on the duration of platelet aggregation in vitro was studied. Coumadin was given for 4 consecutive days to 10 healthy adults who were followed over a period of 9 days. The duration of adenosine diphosphate-induced platelet aggregation in platelet-rich plasma, the prothrombin time, and the platelet count of platelet-rich plasma were measured. Four other healthy adults received placebos and participated in a double-blind study with those receiving Coumadin.
Although administration of Coumadin caused a prolongation of the prothrombin time to 2 or 21/2 times the normal value, a decrease in the duration of platelet aggregation was not observed. In most individuals who received Coumadin an increase in the duration of platelet aggregation occurred. The effect of Coumadin on platelet aggregation was not consistently related to the prothrombin time or to the platelet count. In the placebo group there was a distinct relation between the duration of platelet aggregation and the platelet count in platelet-rich plasma.
The mean increase in the duration of platelet aggregation when compared to the control value before medication with Coumadin was 37.7%. In the placebo group there was a mean increase of 8.4%. The difference between the two groups is significant (p <0.001). Increased duration of platelet aggregation also occurred in two individuals who received Coumadin over a period of 10 and 16 days respectively.
* Present address: Department of Pathology, University of Duesseldorf, Duesseldorf, Germany.
-
References
- 1 Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. J. appl. Physiol. 03: 365 1950;
- 2 Emmons P. R, Mitchell J. R. A. Postoperative changes in platelet-clumping activity. Lancet. I: 71 1965;
- 3 Gaarder A, Jonsen J, Laland S, Hellem A, Owren P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature (Lond.) 192: 531 1961;
- 4 Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature (Lond.) 202: 765 1964;
- 5 Horlick L. Platelet adhesiveness in normal persons and subjects with atherosclerosis. Effect of high fat meals and anticoagulants on the adhesive index. Amer. J. Cardiol. 08: 459 1961;
- 6 Horlick L. The adhesive index, a measure of platelet stickiness. Its response to myocardial injury and to anticoagulant treatment. In MacMillan R. L , Mustard J. F. (eds.): Anticoagulants and Fibrinolysins. Lea & Febiger; Philadelphia: 1961: 56.
- 7 Hovig T. Release of platelet-aggregating substance (adenosine-diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg.) 09: 264 1963;
- 8 Moolten S, Vroman L. The adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders. I. Measurement of platelet adhesiveness by the glass-wool filter. Amer. J. clin. Path. 19: 701 1949; II. Diagnostic and prognostic significance of platelet adhesiveness. Amer. J. clin. Path. 19: 814 (1949).
- 9 Murphy E. A, Mustard J. F. Dicumarol therapy: some effects on platelets and their relationship to clotting tests. Circ. Res. 08: 1187 1960;
- 10 Murphy E. A, Mustard J. F. Platelet economy during moderate and intensive dicumarol therapy. Lancet. II: 960 1961;
- 11 Murphy E. A, Mustard J. F. Dicumarol therapy and platelet turnover. Circ. Res. 09: 402 1961;
- 12 Murphy E. A, Downie H. G, Rowsell H. C, Mustard F. J. The effects of dicumarol and heparin therapy on platelet economy. The relationship of these changes to thrombus formation. In: MacMillan R. L, Mustard J. F. (eds.): Anticoagulants and Fibrinolysins. Lea & Febiger; Philadelphia: 1961: 68.
- 13 Newland H, Nordöy A. The effect of large doses of warfarin sodium on haemostasis and on ADP-induced platelet aggregation in vivo in the rat; A survey of experimental thrombosis and coumarin anticoagulant therapy. Cardiovasc. Res. (In press.)
- 14 Nordöy A, Chandler A. B. Platelet thrombosis induced by adenosine diphosphate in the rat. Scand. J. Haemat. 01: 16 1964;
- 15 Ödegaard A. E, Skålhegg B. A, Hellem A. J. ADP induced platelet adhesiveness as a diagnostic test in von Willebrand’s disease. Thrombos. Diathes. haemorrh. (Stuttg.) 11: 23 1964;
- 16 Spooner M, Myer O. O. The effect of dicumarol on platelet adhesiveness. Amer. J. Physiol. 142: 279 1944;
- 17 Vassalli P, Simon G, Rouiller C. Ultrastructural study of platelet changes initiated in vivo by thrombin. J. Ultrastruct. Res. 11: 374 1964;
- 18 Weiner M, Zeltmacher K, Reich C, Shapiro S. Platelet adhesiveness. Blood. 03: 1275 1948;
- 19 Wright H. P. The adhesiveness of blood platelets in rabbits treated with dicumarol. J. Path. Bact. 57: 382 1945;
- 20 Zucker M. B, Borrelli J. Viscous metamorphosis of blood platelets produced by thrombin. Fed. Proc. 14: 168 1955;